Henderson Jane's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed May 4, 2026
- Accession no.
- 0001104659-26-055091
- Filed
- May 4, 2026
- Trade date
- May 1, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $164.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson JaneCIK 0001422304 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | SSaleDisposed | −811 | $81.02 | −$65,707.22 | 174,560 | Direct | |
| May 1, 2026 | Common Stock | SSaleDisposed | −900 | $82.60 | −$74,340 | 173,660 | Direct | |
| May 1, 2026 | Common Stock | SSaleDisposed | −289 | $83.16 | −$24,033.24 | 173,371 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.